Analyses for protein kinase D2 substrate using 2D-DIGE and Q-Trap mass-spectrometer.
Analyses for protein kinase D2 substrate using 2D-DIGE and Q-Trap mass-spectrometer.
批准号:
17510167
负责人:
IRIE Atsushi
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Although it has been believed that T lymphocytes (T cells) strictly recognize their cognate antigenic peptides, we found that one amino acid residue-substituted analogue peptide/HLA-DR4 complexes over-expressed on the surface of mouse L cells successfully stimulated the cognate human T cell clone and induced strong proliferative response. This phenomenon suggests that an amino acid sequence with close similarity to the non-self antigenic peptide in a self protein may stimulate unwanted T cell activation that may cause autoimmune diseases. To find out molecules involved in the T cell activation process, we used a panel of inhibitors that suppressed the T cell responses. The results suggested the involvement of protein kinase D (PKD) and actually, activation of PKD was observed in the T cells stimulated with the analogue peptide/HLA-DR4.To seek for the role of PKD in the T cell activation pathway, we carried out Maldi-MS/MS analyses using the Qstar Pulser i high performance mass-spectrom … More eter and found that the PKD present in the T cells was D2-isotype (PKD2), not PKD1. Expression of wild- type PKD2 in the human leukemic T cell line Jurkat revealed that PKD2 was involved in the IL-2 promoter activation after TCR- stimulation. Interestingly, expression of constitutively-active form of PKD2 in Jurkat cells enhanced cell death after TCR-stimulation, suggesting that depending on the PKD2 activity, PKD2 contributes either IL-2 promoter activation or cell death. To search for the possible substrates of PKD2, we performed proteomic analyses using the nuclear extract of Jurkat cells and radioactive ATP for in vitro kinase assay. The reaction mixture was subjected to 2D-gel analysis and one of the phosphorylated (=radioactive) proteins was identified to be SET, also called I2PP2A.To find out the significance of SET phosphorylation by PKD2 in activated T cells, we studied the phosphorylation sites of SET by PKD2. The in vitro kinase assay using various SET mutants revealed that one of the phosphorylation sites of SET by PKD2 is Ser 171. The Ser residue was in accordant with the consensus PKD phosphorylation motif of Leu-X-Lys/Arg-X-X-Ser. SET is known to be the specific inhibitor for protein phosphatase 2A (PP2A) that dephosphorylates ERKs and expression of Ser 171 to Glu mutant of SET in Jurkat cells suppressed ERK phosphorylation compared with the expression of Ser 171 to Ala mutant of SET in Jurkat cells, suggesting that PKD2 might regulate PP2A activity through SET phosphorylation. Less
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
A possible requirement of the scafold function of ZAP-70 associated with the partially phosphorylated TCR-zeta chain for T cell activation induced by altered peptide ligand.
ZAP-70 的支架功能可能需要与部分磷酸化的 TCR-zeta 链相关,以实现由改变的肽配体诱导的 T 细胞激活。
DOI:
--
发表时间:
2006
期刊:
Biochem. Biophys. Res. Commun. 341
影响因子:
--
作者:
[Kim, J.R., Irie, A., Tsukamoto, H., Nishimura, Y.]
通讯作者:
Y.
細胞工学、放射性ATPを用いた二次元電気泳動法によるin vitroキナーゼアッセイ
细胞工程,使用放射性 ATP 进行二维电泳的体外激酶测定
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[K., Tanaka, 入江 厚, 鈴木和幸(共著:8章を分担執筆〉, 入江 厚]
通讯作者:
入江 厚
TCR ligand avidity determines the mode ofB-Raf/Raf-1/ERKactivat leading to the activation of human CD4^+ T cell clone.
TCR配体亲和力决定了导致人CD4+T细胞克隆激活的B-Raf/Raf-1/ERK激活模式。
DOI:
--
发表时间:
2006
期刊:
Eur. J. Immunol. 36
影响因子:
--
作者:
[Tsukamoto, H.ほか]
通讯作者:
H.ほか
TCR ligand avidity determines the mode of B-Raf/Raf-1/ERK activation leading to the activation of human CD4+ T cell clone.
TCR 配体亲和力决定了 B-Raf/Raf-1/ERK 激活的模式,从而导致人 CD4 T 细胞克隆的激活。
DOI:
--
发表时间:
2006
期刊:
Eur.J.Immunol. 36
影响因子:
--
作者:
[Tsukamoto, H. ほか]
通讯作者:
H. ほか
TCR ligand avidity determines the mode of B-Raf/Raf-1/ERK activation leading to the activation of human CD4^+T cell clone.
TCR配体亲和力决定了导致人CD4+T细胞克隆激活的B-Raf/Raf-1/ERK激活模式。
DOI:
--
发表时间:
期刊:
Eur.J.Immunol. (発表予定)
影响因子:
--
作者:
[Tsukamoto, H.ほか]
通讯作者:
H.ほか
共 12 条
Mechanism for cell fusion based on phospholipid dynamics in osteoclasts
-
批准号:17K19737
-
项目类别:Grant-in-Aid for Challenging Research (Exploratory)
-
资助金额:$3.99万
-
财政年份:2017
-
负责人:IRIE Atsushi
-
依托单位:
Phospholipid dynamics in osteoclast fusion
-
批准号:26670675
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2014
-
负责人:IRIE Atsushi
-
依托单位:
Identification of substrate molecules on the host immune cells of bacterial proteases by using radioisotopes and mass spectrometry.
-
批准号:23510243
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.49万
-
财政年份:2011
-
负责人:IRIE Atsushi
-
依托单位:
Identification of kinase substrates by using radioactive ATP and LC-Maldi-MS/MS
-
批准号:20510191
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2008
-
负责人:IRIE Atsushi
-
依托单位:
Analyses for phosphoproteins in activated T lymphocytes using Maldi-MS/MS method.
-
批准号:15510165
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2003
-
负责人:IRIE Atsushi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
疏肝补肾毓麟汤通过激活EP1/PKC/Nrf2通路抑制铁死亡改善少弱精子症的机制研究
-
批准号:JCZRLH202601317
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
铁蛋白磷酸化通过氧化应激-ROS/PKC轴调控亚细胞定位逆转卵巢癌耐药的机制研究
-
批准号:JCZRLH202601670
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
pH/ROS双响应Fe3O4-NP激活 PKCβ2/ACSL4抑制支架内再狭窄的作用及机制研究
-
批准号:2026JJ81986
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:段景锋
-
依托单位:
PKCδ/EGR1/PHGDH 轴调控丝氨酸代谢促进内皮细胞衰老在糖尿病创面血管新生障碍中的机制研究
-
批准号:JCZRQNB202600620
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
钩吻素子通过GlyR调控PKC/NLRP3介导的巨噬细胞焦亡以减轻急性肺损伤的机制研究
-
批准号:2026JJ60021
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:徐小庆
-
依托单位:
肿瘤相关成纤维细胞调控SPP1/ PKCα介导铁死亡在宫颈癌化疗耐药中的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:胡雪媚
-
依托单位:
PKC γ通过调节线粒体蛋白的磷酸化减轻脑缺血再灌注损伤的实验研究
-
批准号:2025JJ50618
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:曾六旺
-
依托单位:
基于F/IGF1R/PKC ζ 通路研究夏枯草中
Mesonolic acid B抑制RSV感染性肺炎的
作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:唐维
-
依托单位:
基于TAAR1-PKC-CRF信号通路探究肠道菌群代谢产物苯乙胺在腹泻型肠易激综合征发病中的作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:蔡力
-
依托单位:
基于5-HT–[Ca2+]i–PKC信号通路研究葎草制剂通过改善炎症诱导的内质网应激和间隙连接抑制促进糖尿病足创口愈合的机制
-
批准号:JCZRLH202501287
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位: